This figure excludes the cost of the vaccine and its storage and distribution as this information is commercially confidential.
It would be a reasonable assumption that extending the programme to boys would incur additional administration costs of about 50% of the above figure, i.e. £3.9m pa. Given that most boys would be vaccinated in schools alongside girls, this might in fact be an over-estimate of the costs.
The cost of the vaccine in the UK is unknown but information is available for Italy which shows that one region (Veneto) purchased the quadrivalent vaccine (Gardasil) for £27 per dose.[ii]
Assuming that the price is the same in the UK (and it would probably be cheaper in the UK given the volume of vaccine purchased), the cost of vaccinating 367,000 12-year old boys (based on a 90% uptake) with two doses would be £17,836,200 pa.
The total cost of vaccinating boys would therefore be: £17,836,200 + £3,900,000 = £21,736,200.
If the vaccine could be purchased in the UK at £25 per dose, this would bring the total cost down to £20,415,000.
HPV Action therefore estimates the cost of vaccinating all boys as being in the region of £20-22m pa.